giant basal cell carcinoma of the face
Authors
abstract
this case report describes a 59-year-old woman with a giant basal cell carcinoma on the face neglected for 11 years. surgical resection of the lesion resulted in a 13 × 11 cm defect. issues regarding the adequately safe surgical margins and the management of the resultant defect through modern wound dressing technologies are discussed. keywords : giant basal cell carcinoma, modern dressing, gel dressing, silver dressing, safe margin
similar resources
Basal cell carcinoma of the lower extremities
Background: Basal cell carcinoma (BCC), the most common form of skin cancer, usually occurs in the sun-exposed areas of the body like head and neck, yet is also seen in unexpected sites. Myriad studies have mentioned a lower limb BCC incidence rate of 1.5-13.5%.Methods: The present retrospective cross-sectional study was conducted on 650 BCC patients, who were referred to the dermatology tumor ...
full textGiant Basal Cell Carcinoma of the Scalp
DESCRIPTION A 60-year-old woman presented with a 15 × 15-cm fungating tumor of the posterior scalp.
full textGiant vulvar basal cell carcinoma.
To cite: Garg M, Sharma P, Gupta S, et al. BMJ Case Rep Published online: [please include Day Month Year] doi:10.1136/bcr-2013200180 DESCRIPTION We report a case of 30-year-old woman presented with giant, foul smelling ulcerated growth involving the vulva. The growth was involving the whole of labia majora, minora and adjacent skin associated with itching, bleeding and discharge (figure 1). The...
full textGiant basal cell carcinoma of the scalp
A 64-year-old man, phototype V in Fitzpatrick scale, presented with a 5-year history of a slowly extending ulcer of the scalp. He had a past medical history of diabetes mellitus and ionizing radiation for tinea capitis in childhood. The physical examination revealed an oval-shaped ulcer measuring 7 cm in width x 5 cm in length, with a raised pigmented border; the center was alopecic, scattered ...
full textThe Usefulness of CD10 in Distinguishing between Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma
Background & Objectives: CD10 is a cell surface enzyme with metalloendopeptidase activity, also known as Common Acute Lymphoblastic Leukaemia Antigen, which mainly serves as a marker for acute lymphoblastic leukemia (ALL). To date and to the best of our knowledge, only few comparative immunohistochemical studies have assessed CD10 expression in cutaneous epithelial neoplasms. Our goal was to d...
full textMy Resources
Save resource for easier access later
Journal title:
journal of craniomaxillofacial researchجلد ۱، شماره ۱-۲، صفحات ۲۸-۲۹
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023